New Breakthrough in Treating Alzheimer’s The U.S. Food and Drug Administration approved Aduhelm for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Discover how this will affect you, or your loved ones!
IMPORTANT LINKS
Information about the Duke-UNC Alzheimer's Disease Research Center Click Here
Information about the Duke Memory Disorders Clinic Click Here
Information about clinical drug trials Additional Click Here
Information about clinical trials Click Here
Information about aducanumab at Duke Click Here
Let's Get Social ...
Visit my website click here
Facebook Click Here
Instagram Click Here
Twitter Click Here